Hhamclav Dry Syrup is a combination antibiotic formulation containing Amoxycillin 200 mg and Clavulanic Acid 28.5 mg per 5 ml of reconstituted suspension. Amoxycillin is a broad-spectrum beta-lactam antibiotic belonging to the penicillin class, effective against a wide range of gram-positive and gram-negative bacteria by inhibiting bacterial cell wall synthesis. Clavulanic Acid is a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation by beta-lactamase-producing bacteria, thereby extending its antibacterial spectrum. Hhamclav Dry Syrup is indicated for the treatment of various bacterial infections including respiratory tract infections, otitis media, sinusitis, urinary tract infections, skin and soft tissue infections, and dental infections. It is particularly useful in infections caused by beta-lactamase-producing strains resistant to Amoxycillin alone. The dry syrup formulation is suitable for pediatric patients who have difficulty swallowing tablets, allowing accurate dosing based on body weight. The medication should be reconstituted with the specified amount of water before administration and stored as per guidelines to maintain stability. Use of Hhamclav Dry Syrup should be guided by susceptibility patterns and prescribed by a healthcare professional to minimize resistance development and ensure optimal therapeutic outcomes.